TESARO is an oncology-focused biopharmaceutical company.
TESARO is dedicated to improving the lives of cancer patients by developing and providing safer and more effective therapeutics and supportive care products.
Contact
TESARO Bio GmbH.
Poststrasse 6
6300 ZUG
Switzerland
| www.tesarobio.com
|
The VP of Medtronic’s Benelux, Central Europe, Greece and Israel cluster highlights the global medtech giant’s efforts to position itself as the partner of choice to tackle prevailing global healthcare…
The southern Swiss canton of Ticino does not have the life science reputation of Basel, Zurich or Geneva, but benefits from an open business environment, strategic location, and a thriving network…
Markus Arigoni, CEO of Ticino-based micronization specialists Micro-Macinazione, describes the scope of the company’s operations, the enlargement of the firm’s R&D capacities, and emerging trends in the micronization niche. Micro-Macinazione…
By his own admission. Metrohm CEO Jodok Reinhardt has a dream job. He reveals how the company has become a successful and slightly different outfit when it comes to supplying…
Gabriel Haering, CEO of API manufacturer Cerbios, highlights the importance of “Swiss-ness” to the company’s brand, their attentiveness to diversification and scaling the value chain, and the future prospects for Swiss…
Susanne Hoeppner, GM of Astellas Switzerland and board member of vips, discusses her key priorities, the culture of Swiss pharma, and the industry-wide push for faster approval times. Ms. Hoeppner,…
Treating common skin, hair and scalp conditions with “close to nature” products, the 127-year-old family company Rausch has effective and high quality products, but is working to reposition the brand…
Diabetes is well managed in Switzerland’s patient-centric healthcare system, yet with new data showing Novo Nordisk’s GLP-1 has strong cardiovascular benefits, the company is working to drive a change in…
The managing director of CordenPharma Switzerland elaborates on the role the Swiss facility plays within CordenPharma. He furthermore highlights how the company is tailoring their service offering to cater to…
The general manager of NNE Switzerland highlights the special pharmaceutical engineering focus of the company, allowing them to anticipate the latest trends and adjust to cater to their clients’ needs.…
The Chief Scientific Officer and President of Glenmark Pharmaceuticals Swiss R&D Center elaborates on Glenmark’s endeavor to venture up the pharmaceutical value chain and discusses the company’s R&D strategy. Furthermore,…
In the marketing-driven dermocosmetics sector, the Swiss cosmetics association has recently achieved the passage of a strict new law limiting the usage of the “made in Switzerland” claim for cosmetics…
See our Cookie Privacy Policy Here
